This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 115,66 per year only 9,64 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
With over 1 million therapies conducted worldwide, REVIV is a leader in the benefits of B12 injections and IV therapy
It is less important to pick an expensive one than to choose a good one
Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats
In studies with rodents, GLP-1 medicines caused thyroid tumors, including thyroid cancer
Levels of GHK-Cu in the body naturally decline during aging [2]